Back to Boston Trust Walden Corp Boston Trust Walden Corp

NVONVO

Showing 9 of 31 quarters

Position history for Boston Trust Walden CorpBoston Trust Walden Corp's holdings in Novo Nordisk A/S

Yes. Boston Trust Walden holds 12,091 shares of NVO (Novo Nordisk), worth $458,370, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Boston Trust Walden has held NVO in every 13F on record since Q1 2019, 31 quarterly filings.

Current Value

$458,370

Current Shares

12,091

Total Value Change

-$180,560

Total Shares Change

+6,725

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
12,091
0.0%
$458,3700.0%$37.91
0
2026-Q2
Increased
12,091
+0.5%
$579,6430.0%$47.34
24
2026-Q1
Unchanged
12,036
0.0%
$442,3230.0%$36.29
0
2025-Q4
Unchanged
12,036
0.0%
$612,3920.0%$48.46
0
2025-Q3
Unchanged
12,036
0.0%
$667,8780.0%$52.85
0
2025-Q2
Increased
12,036
+124.3%
$830,7250.0%$65.01
40
2025-Q1
Unchanged
5,366
0.0%
$372,6150.0%$65.40
0
2024-Q4
Unchanged
5,366
0.0%
$461,5830.0%$79.73
0
2024-Q3
Unchanged
5,366
0.0%
$638,9300.0%$110.37
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used